Tier 4 — mechanistic
Exogenous α-ketoglutarate Modulates Redox Metabolism and Functions of Human Dendritic Cells, Altering Their Capacity to Polarise T Cell Response
International Journal of Biological Sciences
2024
20(3):1064-1087
Bibliography
- PubMed
- PMID 38322117
- PubMed Central
- PMC10845299
- Funding
- Supported by Serbian academic research funding reported in the paper.
- Competing interests
- The authors reported no Ca-AKG supplement-product clinical intervention.
Study snapshot
| Design | Mechanistic ex-vivo/in-vitro study using human monocyte-derived dendritic cells and T-cell co-cultures. |
|---|---|
| Model | Human monocyte-derived dendritic cells and allogeneic T cells. |
| Sample | Multiple independent donor experiments. |
| Intervention | Non-toxic exogenous AKG during dendritic-cell differentiation and activation. |
| Duration | Multi-day cell differentiation and co-culture protocols. |
| Endpoints | Dendritic-cell maturation; Th1/Th2/Th17 polarization; Regulatory T cells; IL-1β; Autophagy; OXPHOS and glycolysis |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Citation network
Articles citing this research paper
Biohack Blueprint analyses that reference this study in their evidence base.
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified



